The pharma company has entered into a Settlement Agreement with Forest Laboratories Forest Laboratories & Royalty Pharma Collection Trust to settle and dismiss the outstanding patent litigation related to Glenmarkâs Abbreviated New Drug Application for Milnacipran Hydrochloride.
| Subscribe To Our Free Newsletter |
